ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.868,51
-0,32%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Mgc Pharmaceuticals Limited (MXC)

  7. Mgc Pharmaceuticals Limited (MXC) News

MXC

Mgc Pharmaceuticals (MXC)

Mgc Pharmaceuticals Limited
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:MXC
DatumZeitQuelleÜberschriftSymbolFirma
03/04/202408h30RNS Regulatory NewsLondon Stock Exchange Notice Suspension - MGC Pharmaceuticals LimitedLSE:MXCMgc Pharmaceuticals Limited
02/04/202416h40RNS Regulatory NewsMGC Pharmaceuticals Limited Change of name to Argent BioPharma LimitedLSE:MXCMgc Pharmaceuticals Limited
28/03/202410h12RNS Regulatory NewsMGC Pharmaceuticals Limited PDMR NotificationLSE:MXCMgc Pharmaceuticals Limited
28/03/202410h07RNS Regulatory NewsMGC Pharmaceuticals Limited Refinancing of Convertible Securities AgreementLSE:MXCMgc Pharmaceuticals Limited
18/03/202409h23RNS Regulatory NewsMGC Pharmaceuticals Limited Results of General MeetingLSE:MXCMgc Pharmaceuticals Limited
29/02/202418h00Alliance NewsAlliance NewsEARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payoutLSE:MXCMgc Pharmaceuticals Limited
29/02/202410h36RNS Regulatory NewsMGC Pharmaceuticals Limited Half-year ReportLSE:MXCMgc Pharmaceuticals Limited
19/02/202417h00RNS Regulatory NewsMGC Pharmaceuticals Limited Update - Application for Admission to TradingLSE:MXCMgc Pharmaceuticals Limited
13/02/202412h54Alliance NewsAlliance NewsIN BRIEF: MGC Pharmaceuticals proposes name change to Argent BiopharmaLSE:MXCMgc Pharmaceuticals Limited
13/02/202411h00RNS Regulatory NewsMGC Pharmaceuticals Limited Dispatch of General Meeting DocumentsLSE:MXCMgc Pharmaceuticals Limited
13/02/202410h01RNS Regulatory NewsMGC Pharmaceuticals Limited Application for Admission to TradingLSE:MXCMgc Pharmaceuticals Limited
13/02/202408h30UK RegulatoryMGC Pharma Rebrands as Argent BioPharma in Strategic TransformationLSE:MXCMgc Pharmaceuticals Limited
31/01/202408h30RNS Regulatory NewsMGC Pharmaceuticals Limited December 2023 Quarter Activity ReportLSE:MXCMgc Pharmaceuticals Limited
11/01/202410h54UK RegulatoryMGC Pharmaceuticals Limited Director/PDMR ShareholdingLSE:MXCMgc Pharmaceuticals Limited
22/12/202310h09UK RegulatoryMGC Pharmaceuticals Limited Company Update & Placing to Raise US$500,000LSE:MXCMgc Pharmaceuticals Limited
19/12/202319h04Alliance NewsAlliance NewsMGC Pharma gets Saudi approval for Covid-19 over-the-counter treatmentLSE:MXCMgc Pharmaceuticals Limited
19/12/202308h57RNS Non-RegulatoryMGC Pharmaceuticals Limited ArtemiC(TM) receives FDA Approval in Saudi ArabiaLSE:MXCMgc Pharmaceuticals Limited
18/12/202310h06RNS Non-RegulatoryMGC Pharmaceuticals Limited Non-Deal Roadshow Presentation December 2023LSE:MXCMgc Pharmaceuticals Limited
01/12/202309h09UK RegulatoryMGC Pharmaceuticals Limited Corporate Update - Board and UK Adviser ChangesLSE:MXCMgc Pharmaceuticals Limited
30/11/202310h08UK RegulatoryMGC Pharmaceuticals Limited Results of Shareholder's Annual General MeetingLSE:MXCMgc Pharmaceuticals Limited
16/11/202314h51UK RegulatoryMGC Pharmaceuticals Limited Holding(s) in CompanyLSE:MXCMgc Pharmaceuticals Limited
13/11/202310h15UK RegulatoryMGC Pharmaceuticals Limited Holding(s) in CompanyLSE:MXCMgc Pharmaceuticals Limited
09/11/202311h47UK RegulatoryMGC Pharmaceuticals Limited Holding(s) in CompanyLSE:MXCMgc Pharmaceuticals Limited
08/11/202312h52UK RegulatoryMGC Pharmaceuticals Limited Holding(s) in CompanyLSE:MXCMgc Pharmaceuticals Limited
08/11/202311h00UK RegulatoryMGC Pharmaceuticals Limited Capital Consolidation and US$7.9m PlacementLSE:MXCMgc Pharmaceuticals Limited
01/11/202317h54Alliance NewsAlliance NewsTRADING UPDATES: Premier Miton sizes up Tellworth InvestmentsLSE:MXCMgc Pharmaceuticals Limited
01/11/202312h30UK RegulatoryMGC Pharmaceuticals Limited Consolidation and New Fund RaisingLSE:MXCMgc Pharmaceuticals Limited
01/11/202312h03UK RegulatoryMGC Pharmaceuticals Limited MGC Secures US$7.9 Million In Firm CommitmentsLSE:MXCMgc Pharmaceuticals Limited
31/10/202310h32UK RegulatoryMGC Pharmaceuticals Limited Dispatch of Annual General Meeting DocumentsLSE:MXCMgc Pharmaceuticals Limited
30/10/202308h16UK RegulatoryMGC Pharmaceuticals Limited September 2023 Quarter Activity ReportLSE:MXCMgc Pharmaceuticals Limited
 Showing the most relevant articles for your search:LSE:MXC

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
TG
RHM
Rheinmetall
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
FX
EURJPY
Euro vs Yen
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
TG
DBK
Deutsche Bank
TG
ALV
Allianz
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
TG
TUI1
Tui
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten